The FINISH-3 trial: A phase 3, international, randomized, single-blind, controlled trial of topical fibrocaps in intraoperative surgical hemostasis

Journal of the American College of Surgeons

Volumn 220, Issue 1, 2015, Pages 70-81

  Bochicchio, Grant V ^a   Gupta, Navyash ^b   Porte, Robert J ^c   Renkens, Kenneth L ^d   Pattyn, Piet ^e   Topal, Baki ^f   Troisi, Roberto Ivan ^e   Muir, William ^g   Chetter, Ian ^h   Gillen, Daniel L ⁱ   Zuckerman, Linda A ^j   Frohna, Paul A ^j  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d INDIANA SPINE GROUP   (United States)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g Spine Surgery   (United States)

^h UNIVERSITY OF HULL   (United Kingdom)

ⁱ 5226 Donald Bren Hall   (United States)

^j Clinical Development ProFibrix Inc Medicines Company   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN GLUE; FIBRINOGEN PLUS THROMBIN; GELATIN SPONGE; HEMOSTATIC AGENT; GELATIN;

ADULT; ANEMIA; CONFERENCE PAPER; CONSTIPATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRY POWDER; FEMALE; FEVER; FOLLOW UP; HEMOSTASIS; HUMAN; HYPERTENSION; HYPOTENSION; IMMUNOGENICITY; INCISION SITE PAIN; INSOMNIA; INTRAOPERATIVE PERIOD; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; NAUSEA; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PAIN; PROCEDURAL PAIN; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; SOFT TISSUE SURGERY; SPINE SURGERY; SURGERY; VASCULAR SURGERY; VOMITING; ADOLESCENT; AGED; BLOOD LOSS, SURGICAL; CLINICAL TRIAL; COMPARATIVE STUDY; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SURGICAL SPONGE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; FEMALE; FIBRIN TISSUE ADHESIVE; FOLLOW-UP STUDIES; GELATIN; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SURGICAL SPONGES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84916897878     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2014.09.019     Document Type: Conference Paper

References (22)

1. H.E. Achneck, S. Bantayehu, and R.M. Jamiolowski A comprehensive review of topical hemostatic agents: Efficacy and recommendations for use Ann Surg 251 2010 217 228
2. W.D. Spotnitz Hemostats, sealants, and adhesives: a practical guide for the surgeon Am Surg 78 2012 1305 1321
3. M. Gabay, and B.A. Boucher An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis Pharmacotherapy 33 2013 935 955
4. H.H. Versteeg, J.W. Heemskerk, M. Levi, and P.H. Reitsma New fundamentals in hemostasis Physiol Rev 93 2013 327 358
5. W.C. Chapman, N. Singla, and Y. Genyk A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis J Am Coll Surg 205 2007 256 265
6. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assn 53 1958 457 481
7. D.R. Cox Regression models and life-tables J R Stat Soc Series B Stat Methodol 34 1972 187 220
8. J.O. Irwin The standard error of an estimate of expectational life J Hygiene 47 1949 457 481
9. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute. Common terminology criteria for adverse events (CTCAE). Version 4. Available at: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010-06-14-QuickReference-5x7.pdf. Accessed October 22, 2014.
10. WHO. Drug Reference List (March 2010 version). Uppsala, Sweden: Uppsala-WHO Collaborating Centre for International Drug Monitoring; 2010.
11. J. Rousou, S. Levitsky, and L. Gonzalez-Lavin Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study J Thorac Cardiovasc Surg 97 1989 194 203
12. J. Lowe, J. Luber, and S. Levitsky Evaluation of the topical hemostatic efficacy and safety of TISSEEL VH S/D fibrin sealant compared with currently licensed TISSEEL VH in patients undergoing cardiac surgery: a phase 3, randomized, double-blind clinical study J Cardiovasc Surg (Torino) 48 2007 323 331
13. R.T. Chalmers, R.C. Darling III, and J.T. Wingard Randomized clinical trial of tranexamic acid-free fibrin sealant during vascular surgical procedures Br J Surg 97 2010 1784 1789
14. Evicel Fibrin Sealant (Human) prescribing information. Ethicon, Inc. 2009. Available at: http://hostedvl106.quosavl.com/cgi-isapi/server.dll?8000?IFUs?rkumar12@its.jnj.com?GetOneDocPureFullTxt?24vnohukg3l4tbqe1t9fo4ahno?3. Accessed June 12, 2014.
15. A. Frilling, G.A. Stavrou, and H.J. Mischinger Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial Langenbecks Arch Surg 390 2005 114 120
16. L. Fischer, C.M. Seiler, and C.E. Broelsch Hemostatic efficacy of TachoSil in liver resection compared with argon beam coagulator treatment: an open, randomized, prospective, multicenter, parallel-group trial Surgery 149 2011 48 55
17. F. Maisano, H.K. Kjaergård, and R. Bauernschmitt TachoSil surgical patch versus conventional haemostatic fleece material for control of bleeding in cardiovascular surgery: a randomised controlled trial Eur J Cardiothorac Surg 36 2009 708 714
18. C.P. Fischer, G. Bochicchio, and J. Shen A prospective, randomized, controlled trial of the efficacy and safety of fibrin pad as an adjunct to control soft tissue bleeding during abdominal, retroperitoneal, pelvic, and thoracic surgery J Am Coll Surg 217 2013 385 393
19. US Food and Drug Administration FDA safety notification: risk of air or gas embolism when using air- or gas- pressurized spray devices 2010 Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm218523.htm Accessed June 12, 2014
20. European Medicines Agency. European Medicines Agency recommends new advice on safer use of fibrin sealant spray applications. 2012. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news-and-events/news/2012/12/news-detail-001674.jsp&mid=WC0b01ac058004d5c1. Accessed June 12, 2014.
21. B. Horowitz, and M. Busch Estimating the pathogen safety of manufactured human plasma products: application to fibrin sealants and to thrombin Transfusion 48 2008 1739 1753
22. M.A. Carlson, J. Calcaterra, and J.M. Johanning A totally recombinant human fibrin sealant J Surg Res 187 2014 334 342